Survivin/BIRC5-derived peptide disrupts survivin dimerization and cell division and induces multifaceted anti-cancer effects

Manikandan Santhanam; Venkatadri Babu; Anna Shteinfer-Kuzmine; Swaroop Kumar Pandey; Larisa Gheber; Gilead Raday; Varda Shoshan-Barmatz

doi:10.1016/j.omton.2026.201142

Survivin/BIRC5-derived peptide disrupts survivin dimerization and cell division and induces multifaceted anti-cancer effects

Manikandan Santhanam
, Venkatadri Babu
, Anna Shteinfer-Kuzmine
, Swaroop Kumar Pandey
, Larisa Gheber
, Gilead Raday
, Varda Shoshan-Barmatz

Research output: Contribution to journal › Comment/debate

Abstract

(Molecular Therapy: Oncology 34, 1−25; March 2026) In the originally published version of this article, KMH2-LC cells were incorrectly described as human anaplastic thyroid carcinoma but should be KMH2 (human Hodgkin lymphoma). The authors apologize for this error.

Original language	English
Article number	201142
Journal	Molecular Therapy Oncology
Volume	34
Issue number	1
DOIs	https://doi.org/10.1016/j.omton.2026.201142
State	Published - 19 Mar 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Molecular Medicine
Oncology
Cancer Research
Pharmacology (medical)

Access to Document

10.1016/j.omton.2026.201142

Cite this

@article{4395e1daeecc4fb48b2b7680a018d641,

title = "Survivin/BIRC5-derived peptide disrupts survivin dimerization and cell division and induces multifaceted anti-cancer effects",

abstract = "(Molecular Therapy: Oncology 34, 1−25; March 2026) In the originally published version of this article, KMH2-LC cells were incorrectly described as human anaplastic thyroid carcinoma but should be KMH2 (human Hodgkin lymphoma). The authors apologize for this error.",

author = "Manikandan Santhanam and Venkatadri Babu and Anna Shteinfer-Kuzmine and Pandey, \{Swaroop Kumar\} and Larisa Gheber and Gilead Raday and Varda Shoshan-Barmatz",

note = "Publisher Copyright: {\textcopyright} 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy. This is an open access article under the CC BY license. http://creativecommons.org/licenses/by/4.0/",

year = "2026",

month = mar,

day = "19",

doi = "10.1016/j.omton.2026.201142",

language = "English",

volume = "34",

journal = "Molecular Therapy Oncology",

issn = "2950-3299",

publisher = "Cell Press",

number = "1",

}

TY - JOUR

T1 - Survivin/BIRC5-derived peptide disrupts survivin dimerization and cell division and induces multifaceted anti-cancer effects

AU - Santhanam, Manikandan

AU - Babu, Venkatadri

AU - Shteinfer-Kuzmine, Anna

AU - Pandey, Swaroop Kumar

AU - Gheber, Larisa

AU - Raday, Gilead

AU - Shoshan-Barmatz, Varda

N1 - Publisher Copyright: © 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy. This is an open access article under the CC BY license. http://creativecommons.org/licenses/by/4.0/

PY - 2026/3/19

Y1 - 2026/3/19

N2 - (Molecular Therapy: Oncology 34, 1−25; March 2026) In the originally published version of this article, KMH2-LC cells were incorrectly described as human anaplastic thyroid carcinoma but should be KMH2 (human Hodgkin lymphoma). The authors apologize for this error.

AB - (Molecular Therapy: Oncology 34, 1−25; March 2026) In the originally published version of this article, KMH2-LC cells were incorrectly described as human anaplastic thyroid carcinoma but should be KMH2 (human Hodgkin lymphoma). The authors apologize for this error.

UR - https://www.scopus.com/pages/publications/105038902855

U2 - 10.1016/j.omton.2026.201142

DO - 10.1016/j.omton.2026.201142

M3 - Comment/debate

C2 - 41659921

AN - SCOPUS:105038902855

SN - 2950-3299

VL - 34

JO - Molecular Therapy Oncology

JF - Molecular Therapy Oncology

IS - 1

M1 - 201142

ER -

Survivin/BIRC5-derived peptide disrupts survivin dimerization and cell division and induces multifaceted anti-cancer effects

Abstract

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this